JP2022516496A5 - - Google Patents
Info
- Publication number
- JP2022516496A5 JP2022516496A5 JP2021537987A JP2021537987A JP2022516496A5 JP 2022516496 A5 JP2022516496 A5 JP 2022516496A5 JP 2021537987 A JP2021537987 A JP 2021537987A JP 2021537987 A JP2021537987 A JP 2021537987A JP 2022516496 A5 JP2022516496 A5 JP 2022516496A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- linker
- chimeric receptor
- receptor polypeptide
- tcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019071609 | 2019-01-14 | ||
| CNPCT/CN2019/071609 | 2019-01-14 | ||
| PCT/CN2020/071947 WO2020147708A1 (en) | 2019-01-14 | 2020-01-14 | Chimeric receptor polypeptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022516496A JP2022516496A (ja) | 2022-02-28 |
| JP2022516496A5 true JP2022516496A5 (https=) | 2023-01-19 |
Family
ID=71614406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537987A Pending JP2022516496A (ja) | 2019-01-14 | 2020-01-14 | キメラ受容体ポリペプチド及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230192805A1 (https=) |
| EP (1) | EP3911370A4 (https=) |
| JP (1) | JP2022516496A (https=) |
| KR (1) | KR20210116478A (https=) |
| CN (1) | CN113164626A (https=) |
| AU (1) | AU2020208110A1 (https=) |
| CA (1) | CA3126422A1 (https=) |
| SG (1) | SG11202106257WA (https=) |
| WO (1) | WO2020147708A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210104772A (ko) | 2018-12-14 | 2021-08-25 | 블루버드 바이오, 인코포레이티드. | 이량체화제로 조절된 면역수용체 복합체 |
| WO2022228579A1 (en) * | 2021-04-30 | 2022-11-03 | Nanjing Legend Biotech Co., Ltd. | Chimeric antigen receptors targeting gpc3 and methods of use thereof |
| CN117897411A (zh) * | 2021-06-30 | 2024-04-16 | 华夏英泰（北京）生物技术有限公司 | 一种多靶点合成t细胞受体抗原/抗体受体及其应用 |
| JP2024525727A (ja) * | 2021-07-14 | 2024-07-12 | ２セブンティ バイオ インコーポレイテッド | 抗体由来の結合ドメインに融合した操作されたｔ細胞受容体 |
| WO2023164698A2 (en) * | 2022-02-27 | 2023-08-31 | Health Research, Inc. | FOLATE RECEPTOR ALPHA -TARGETING BI-SPECIFIC T CELL ENGAGERS (BiTEs) AND USES THEREOF |
| CN114560948B (zh) * | 2022-03-07 | 2023-05-23 | 中国人民解放军空军军医大学 | 一种嵌合抗原受体、car-t细胞及其应用 |
| CN114573712B (zh) * | 2022-03-07 | 2023-05-12 | 中国人民解放军空军军医大学 | 一种嵌合抗原受体、car-t细胞及其应用 |
| CN114560949B (zh) * | 2022-03-07 | 2023-09-26 | 中国人民解放军空军军医大学 | 一种具有增强car-t细胞抗肿瘤能力的嵌合抗原受体、d-car-t细胞及其应用 |
| CN119032110A (zh) * | 2022-04-07 | 2024-11-26 | 恺兴生命科技(上海)有限公司 | 嵌合多肽及其应用 |
| AR130387A1 (es) * | 2022-09-08 | 2024-12-04 | Hoffmann La Roche | Receptores de linfocitos t recombinantes |
| WO2024100136A1 (en) * | 2022-11-08 | 2024-05-16 | Gadeta B.V. | Novel method for obtaining gamma t-cell (or delta t-cell) receptor chains (or gamma delta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response |
| CN120435501A (zh) * | 2022-12-30 | 2025-08-05 | 上药生物治疗（香港）有限公司 | 细胞原位分泌抗体及其用途 |
| CN117074674B (zh) * | 2023-03-23 | 2024-01-23 | 武汉勖瑞生物科技有限责任公司 | 检测N-乙酰-β-D氨基葡萄糖苷酶的胶体金试纸及其制备方法 |
| WO2024206992A2 (en) * | 2023-03-30 | 2024-10-03 | Yale University | Universal antibody receptors, guar-t cells and therapeutic use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0908613D0 (en) * | 2009-05-20 | 2009-06-24 | Immunocore Ltd | T Cell Reseptors |
| LT3030581T (lt) * | 2013-08-07 | 2021-05-25 | Affimed Gmbh | Antikūno surišimo vietos specifiškos egfrviii |
| US9212225B1 (en) * | 2014-07-01 | 2015-12-15 | Amphivena Therapeutics, Inc. | Bispecific CD33 and CD3 binding proteins |
| CA2970924A1 (en) * | 2014-10-31 | 2016-05-06 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Tetravalent tlr9 bispecific antibody |
| HRP20191873T1 (hr) * | 2014-12-12 | 2020-01-24 | Bluebird Bio, Inc. | Kimerni antigenski receptori |
| PL3298033T5 (pl) * | 2015-05-18 | 2023-10-30 | TCR2 Therapeutics Inc. | Kompozycje i zastosowania medyczne do reprogramowania TCR z zastosowaniem białek fuzyjnych |
| GB201522592D0 (en) * | 2015-12-22 | 2016-02-03 | Immunocore Ltd | T cell receptors |
| GB201604953D0 (en) * | 2016-03-23 | 2016-05-04 | Immunocore Ltd | T cell receptors |
| CN105777911B (zh) * | 2016-04-12 | 2019-07-02 | 上海优卡迪生物医药科技有限公司 | 抗bcma嵌合抗原受体、编码基因、重组表达载体及其构建方法和应用 |
| CN110582509A (zh) * | 2017-01-31 | 2019-12-17 | 诺华股份有限公司 | 使用具有多特异性的嵌合t细胞受体蛋白治疗癌症 |
| JP7538601B2 (ja) * | 2017-04-26 | 2024-08-22 | ユーリカ セラピューティックス， インコーポレイテッド | キメラ活性化受容体及びキメラ刺激受容体を発現する細胞並びにその使用 |
-
2020
- 2020-01-14 US US17/422,475 patent/US20230192805A1/en not_active Abandoned
- 2020-01-14 SG SG11202106257WA patent/SG11202106257WA/en unknown
- 2020-01-14 CN CN202080006993.7A patent/CN113164626A/zh active Pending
- 2020-01-14 JP JP2021537987A patent/JP2022516496A/ja active Pending
- 2020-01-14 AU AU2020208110A patent/AU2020208110A1/en active Pending
- 2020-01-14 KR KR1020217022271A patent/KR20210116478A/ko not_active Withdrawn
- 2020-01-14 CA CA3126422A patent/CA3126422A1/en active Pending
- 2020-01-14 EP EP20741668.6A patent/EP3911370A4/en active Pending
- 2020-01-14 WO PCT/CN2020/071947 patent/WO2020147708A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022516496A5 (https=) | ||
| US20250059283A1 (en) | Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof | |
| US20240294599A1 (en) | Chimeric antigen receptors targeting g-protein coupled receptor and uses thereof | |
| EP4148125A1 (en) | Engineered immune cell for allotransplantation | |
| CN113321737A (zh) | 新型嵌合抗原受体及其用途 | |
| WO2021129559A1 (zh) | T细胞受体融合蛋白及其用途 | |
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| WO2021249462A1 (zh) | 表达nk抑制性分子的工程化免疫细胞及其用途 | |
| US20240009308A1 (en) | Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof | |
| JP2024505955A (ja) | 新型キメラ抗原受容体及びその使用 | |
| WO2022218226A1 (zh) | 工程化免疫细胞及其用途 | |
| CN117004603A (zh) | 一种cd7基因被敲除的工程化免疫细胞及其用途 | |
| WO2023207390A1 (zh) | 一种ciita基因被敲除的工程化免疫细胞及其用途 | |
| CN117187185A (zh) | 一种工程化免疫细胞及其用途 | |
| WO2023051361A1 (zh) | 工程化免疫细胞及其用途 | |
| CN115725503A (zh) | 工程化免疫细胞 | |
| CN117430712A (zh) | 靶向cxcr6的嵌合抗原受体及其用途 | |
| WO2026082164A1 (en) | A modified dual-targeting t cell receptor complex and its pharmaceutical application thereof | |
| WO2023083003A1 (zh) | 工程化免疫细胞及其用途 | |
| WO2023241141A1 (zh) | 靶向ccr8的嵌合抗原受体及其用途 | |
| WO2025035310A1 (zh) | 工程化免疫细胞及其用途 | |
| CN115725504A (zh) | 工程化免疫细胞及其用途 | |
| CN115704010A (zh) | 工程化免疫细胞及其用途 | |
| HK40084045A (en) | Engineered immune cell for allotransplantation | |
| CA2974434C (en) | Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof |